Company overview
Basic information
Company name
Biologic design, MB
Company code
306337251
VAT code
LT100020048511
Registered address
Vilnius, Giedraičių g. 39-R53, LT-09302
Registration date
2023-06-14
Company age: 3 y. 4 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Engineering design and construction activities
Ownership form
Private without foreign capital
MB Biologic design
Company code: 306337251
Address: Vilnius, Giedraičių g. 39-R53, LT-09302
VAT code: LT100020048511
Description
This description was generated by artificial intelligence.
Biologic design, MB (company code 306337251) is a private small partnership registered in 2023 and operating as a national private non-financial company. It is a micro-sized entity with a governance structure described as CEO only and private ownership held by Lithuanian natural and legal persons, with no foreign investor capital. The company is based in Vilnius, at Giedraiciu g. 39-R53, Vilnius city municipality, Vilnius county. Its main activity is classified under EVRK N.71.12.10, engineering design and construction activities.
Financially, the company reported revenue of €64.8K in 2024 and net profit of €16.8K, with a profit margin of 25.9%. In 2025, over a 201-day period, it recorded a net loss of €1.1K. At the end of 2025, equity stood at €3.7K, total assets at €3.9K, and liabilities at €158, indicating a balance sheet financed mainly by equity. The latest financial metrics show negative return on equity and return on assets, reflecting the weaker result in 2025 compared with 2024.
Financially, the company reported revenue of €64.8K in 2024 and net profit of €16.8K, with a profit margin of 25.9%. In 2025, over a 201-day period, it recorded a net loss of €1.1K. At the end of 2025, equity stood at €3.7K, total assets at €3.9K, and liabilities at €158, indicating a balance sheet financed mainly by equity. The latest financial metrics show negative return on equity and return on assets, reflecting the weaker result in 2025 compared with 2024.
Download a detailed company report
Make confident decisions with all the information about Biologic design, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.